Incidence, outcomes, and impact of COVID-19 on inflammatory bowel disease: propensity matched research network analysis.

Yousaf Bashir Hadi Parambir S DulaiJustin KupecNabeeha Mohy-Ud-DinVipul JairathFrancis A Farraye Gursimran S Kochhar

Published in: Alimentary pharmacology & therapeutics (2021)

We observed no increase in risk for COVID-19 amongst patients with IBD or risk for de novo IBD after COVID-19 infection. We confirmed prior observations regarding the impact of steroid use on COVID-19 severity in patients with IBD.

Keyphrases

coronavirus disease
sars cov
network analysis
ulcerative colitis
respiratory syndrome coronavirus
risk factors
metabolic syndrome
insulin resistance